FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


23449 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Child: agency involved NOS Child agency involvement status
Child: agency involved NOS Child agency involvement status
Childhood epilepsy with occipital paroxysms Occipital lobe epilepsy
Childhood seizure Seizure
Chilognatha Class Diplopoda (organism)
Chinese restaurant syndrome Monosodium glutamate symptom complex comprises of a set of symptoms with onset after ingestion of monosodium glutamate. The symptoms include migraine headache, urticaria, angioedema or rhinitis.
Chlamydia pneumoniae deoxyribonucleic acid Chlamydophila pneumoniae DNA
Chloral hydrate 250mg/5mL syrup Chloral hydrate 50 mg/mL oral solution
Chloral hydrate suppositories 10gr Chloral hydrate 650 mg rectal suppository
Chloral hydrate suppositories 5gr Chloral hydrate 325 mg rectal suppository
Chloral sedative agent Chloral derivative (substance)
Chloramin T specific extract Product containing tosylchloramide sodium (medicinal product)
Chloramphenicol (class of antibiotic, substance) Chloramphenicol (substance)
Chloramphenicol 0.25% eye drops Chloramphenicol (as chloramphenicol sodium succinate) 2.5 mg/mL eye solution
Chlorhexidine Product containing chlorhexidine (medicinal product)
Chlorhexidine digluconate+amethocaine 0.05/0.015% oral spray Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug)
Chlorhexidine gluconate 0.02% in 70% IMS spray Chlorhexidine gluconate 200 microgram/mL cutaneous spray
Chlorhexidine gluconate 0.02% in 70% IMS spray refill Chlorhexidine gluconate 200 microgram/mL cutaneous spray
Chlorhexidine gluconate 0.5% in 70% IMS solution Chlorhexidine gluconate 50 mg/mL cutaneous solution
Chlorhexidine gluconate 0.5% in 70% IMS spray Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug)
Chlorhexidine gluconate 0.5% in 70% IMS spray refill Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug)
Chlorhexidine gluconate 2%/isopropyl alcohol 70% topical sponge Product containing only chlorhexidine and isopropyl alcohol (medicinal product)
Chlorhexidine gluconate 3.15%/isopropyl alcohol 70% topical swab Product containing only chlorhexidine and isopropyl alcohol (medicinal product)
Chlorhexidine gluconate+ethyl alcohol 1%/61% solution Product containing only chlorhexidine and ethanol (medicinal product)
Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% conventional release oromucosal spray Product containing only chlorhexidine and lidocaine (medicinal product)
Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% throat spray Product containing only chlorhexidine and lidocaine (medicinal product)
Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% throat spray Product containing only chlorhexidine and lidocaine (medicinal product)
Chlorhexidine gluconate+lignocaine hydrochloride 0.2%/0.05% throat spray Product containing only chlorhexidine and lidocaine (medicinal product)
Chlorhexidine gluconate+sodium nitrite 0.5/0.1% in 70% IMS solution Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter and sodium nitrite 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug)
Chlorhexidine hydrochloride+neomycin sulfate Product containing chlorhexidine and neomycin (medicinal product)
Chlorinated phenol disinfectant adverse reaction Chlorinated phenol adverse reaction
Chlorinated phenol disinfectant allergy Allergy to chlorinated phenol (finding)
Chlorobenzoic acid toxicity Poisoning by 4-chlorobenzoic acid
Chloroform substance of abuse - non-pharmaceutical Chloroform
Chlorophenothane Clofenotane
Chloroprocaine hydrochloride 1% injection solution ampule Product containing only chloroprocaine (medicinal product)
Chloroprocaine hydrochloride 2% injection solution ampule Product containing only chloroprocaine (medicinal product)
Chloroprocaine hydrochloride 3% injection solution ampule Product containing only chloroprocaine (medicinal product)
Chloroxylenol Chloroxylenol (substance)
Chlorpheniramine 2mg/ibuprofen 200mg/pseudoephedrine 30mg caplet Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug)
Chlorpheniramine 2mg/ibuprofen 200mg/pseudoephedrine 30mg conventional release oral tablet Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug)
Chlorpheniramine maleate Product containing chlorphenamine (medicinal product)
Chlorpheniramine maleate + methscopolamine nitrate + pseudoephedrine hydrochloride 8mg/2.5mg/120mg m/r tablet Product containing only chlorphenamine and methscopolamine and pseudoephedrine in oral dose form (medicinal product form)
Chlorpheniramine maleate + methscopolamine nitrate + pseudoephedrine hydrochloride 8mg/2.5mg/120mg prolonged-release oral tablet Product containing only chlorphenamine and methscopolamine and pseudoephedrine in oral dose form (medicinal product form)
Chlorpheniramine maleate + pseudoephedrine hydrochloride Product containing chlorphenamine and pseudoephedrine (medicinal product)
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg m/r capsule Chlorphenamine and phenylephrine and phenyltoloxamine only product in oral dose form
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg prolonged-release oral capsule Chlorphenamine and phenylephrine and phenyltoloxamine only product in oral dose form
Chlorpromazine hydrochloride 10mg/5mL syrup Chlorpromazine hydrochloride 2 mg/mL oral solution
Chlorpromazine hydrochloride 150mg m/r capsule Product containing only chlorpromazine in oral dose form (medicinal product form)
Chlorpromazine hydrochloride 150mg prolonged-release oral capsule Product containing only chlorpromazine in oral dose form (medicinal product form)
Chlorpromazine hydrochloride 30mg m/r capsule Product containing only chlorpromazine in oral dose form (medicinal product form)
Chlorpromazine hydrochloride 30mg prolonged-release oral capsule Product containing only chlorpromazine in oral dose form (medicinal product form)
Chlorpromazine hydrochloride 50mg/5mL syrup Product containing precisely chlorpromazine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug)
Chlorpromazine hydrochloride 75mg m/r capsule Product containing only chlorpromazine in oral dose form (medicinal product form)
Chlorpromazine hydrochloride 75mg prolonged-release oral capsule Product containing only chlorpromazine in oral dose form (medicinal product form)
Chlorprothixene overdose Chlorprothixene overdose (disorder)
Chlortetracycline hydrochloride 3% ointment Product containing precisely chlortetracycline 30 milligram/1 gram conventional release cutaneous ointment (clinical drug)
Cholangiogram normal Fluoroscopic cholangiography with contrast normal
Cholangiogram normal post-cholecystectomy Postoperative fluoroscopic cholangiography with contrast normal
Cholangiogram normal post-sphincterotomy Postoperative fluoroscopic cholangiography with contrast normal
Cholecystectomy and operative cholangiogram Cholecystectomy with intraoperative fluoroscopic cholangiography with contrast (procedure)
Cholecystectomy with exploration of common duct with cholangiography Cholecystectomy and exploration of common bile duct with intraoperative fluoroscopic cholangiography with contrast (procedure)
Cholecystocholangiogram Percutaneous transhepatic fluoroscopic cholecystocholangiography with contrast
Choledochotomy - obstruction NOS Incision of common bile duct
Choledochotomy - obstruction NOS Incision of common bile duct
Cholelithiasis NOS Biliary calculus
Cholelithiasis NOS Biliary calculus
Cholera vaccination NOS Administration of cholera vaccine
Cholera vaccination NOS Administration of cholera vaccine
Cholesteatoma with complications Cholesteatoma
Cholesterol analyte Cholesterol
Cholesterol reduction program - declined Cholesterol reduction programme declined
Cholestyramine + sucrose Product containing colestyramine (medicinal product)
Cholestyramine 4g powder Colestyramine 4 g powder for oral suspension sachet
Cholestyramine 4g suspension Colestyramine 4 g powder for oral suspension sachet
Cholestyramine 4g/unit powder Colestyramine 4 g powder for oral suspension sachet
Cholestyramine 4g/unt powder Colestyramine 4 g powder for oral suspension sachet
Cholestyramine+aspartame Product containing colestyramine (medicinal product)
Cholestyramine+aspartame 4g/sachet powder Colestyramine 4 g powder for oral suspension sachet
Choline salicylate 870mg/5ml liquid Product containing precisely choline salicylate 87 milligram/1 gram conventional release oromucosal gel (clinical drug)
Choline salicylate+glycerol 20%/12.6% ear drops Product containing precisely choline 200 milligram/1 milliliter and glycerol 126 milligram/1 milliliter conventional release ear solution (clinical drug)
Choline theophyllinate allergy Allergy to theophylline (finding)
Chondrocalcinosis due to dicalcium phosphate crystals, NOS Chondrocalcinosis caused by dicalcium phosphate crystals
Chondrocalcinosis due to dicalcium phosphate crystals, of other specified site Chondrocalcinosis caused by dicalcium phosphate crystals
Chondrocalcinosis due to dicalcium phosphate crystals, of unspecified site Chondrocalcinosis caused by dicalcium phosphate crystals
Chondrocyte cell Chondrocyte (substance)
Chondrosarcoma - category Chondrosarcoma
Chondrosarcoma, no International Classification of Diseases for Oncology subtype Chondrosarcoma
Choriocarcinoma, no International Classification of Diseases for Oncology subtype Choriocarcinoma (morphologic abnormality)
Choriogonadotropin alfa 10,000iu powder and solvent for injection solution ampule Choriogonadotropin alfa only product in parenteral dose form
Choriogonadotropin alfa 10,000iu powder for conventional release solution for injection ampule Choriogonadotropin alfa only product in parenteral dose form
Choriogonadotropin alfa 1500iu powder and solvent for injection solution ampule Choriogonadotropin alfa only product in parenteral dose form
Choriogonadotropin alfa 1500iu powder for conventional release solution for injection ampule Choriogonadotropin alfa only product in parenteral dose form
Choriogonadotropin alfa 2000iu powder and solvent for injection solution ampule Choriogonadotropin alfa only product in parenteral dose form
Choriogonadotropin alfa 2000iu powder for conventional release solution for injection ampule Choriogonadotropin alfa only product in parenteral dose form
Choriogonadotropin alfa 5000iu powder and solvent for injection solution ampule Product containing only choriogonadotropin (medicinal product)
Choriogonadotropin alfa 5000iu powder for conventional release solution for injection ampule Product containing only choriogonadotropin (medicinal product)
Choroid meningioma Meningioma, chordoid (morphologic abnormality)
Choroid plexus papilloma, no International Classification of Diseases for Oncology subtype Benign choroid plexus papilloma (morphologic abnormality)
Choroideremia co-occurrent with hypopituitarism An X-linked retinal dystrophy characterized by choroideremia, causing in affected males progressive nyctalopia and eventual central blindness. Obesity, moderate intellectual disability and congenital mixed (sensorineural and conductive) deafness are also observed. Female carriers show typical retinal changes indicative of the choroideremia carrier state.
Chromic phosphate, p-32 15mCi injection suspension 10mL vial Chromic phosphate (32-P) only product in parenteral dose form

Start Previous Page 35 of 235 Next End


Reference Sets

Reference set descriptor

Back to Start